P486 Factors influencing the time to and outcome of dose escalation of adalimumab in Crohn's disease patients who achieved steroid-free remission on adalimumab

✍ Scribed by Mantzaris, G.J.; Kyriakos, N.; Papamichael, K.; Archavlis, E.; Tzannetakou, X.; Internos, I.; Anastasiadis, S.; Karatzas, P.; Tsironikos, D.; Drougas, I.

• Book ID: 122143973
• Publisher: Oxford University Press
• Year: 2014
• Tongue: English
• Weight: 69 KB
• Volume: 8
• Category: Article
• ISSN: 1873-9946
• DOI: 10.1016/S1873-9946(14)60606-1